SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Lipocine announced that Phase 3 clinical data for LPCN 1154, an oral brexanolone candidate for postpartum depression, was accepted for oral and poster presentations at the American…
Relay announced initial Phase 2 data showing zovegalisib achieved a 60% volumetric response rate in PIK3CA-driven vascular anomalies patients at 12 weeks, with 89% investigator-rep…
Pitney Bowes Inc. executed a third amendment to its credit agreement dated May 18, 2026, modifying terms with Bank of America as administrative agent and updating schedules and len…
Driven Brands restated financial results for fiscal 2024-2025 due to corrections in lease accounting, cash, payables, and other items, while reporting FY2025 revenue growth of 6.3%…
Entrada shared a corporate presentation on its ENTR-601-44 candidate in Duchenne muscular dystrophy, outlining expectations for open-label period completion by end-2026 and multipl…
Cullinan Therapeutics announced initial clinical data from two Phase 1 studies of CLN-978, a CD19xCD3 T cell engager, showing favorable safety profile and robust B cell depletion w…
The Federal Reserve Board has approved an application submitted by the Stephen M. Calk 2025 Trust. The specific details and implications of the approval were not disclosed in the a…
The Federal Reserve Board does not object to United Texas Bank of Dallas converting from a Federal Reserve-supervised bank to a national bank supervised by the Office of the Comptr…
The Federal Reserve Board has terminated all enforcement actions against UBS Group AG, Credit Suisse AG, and related entities. This action follows UBS's acquisition of Credit Suiss…
The Federal Reserve Board published findings from two surveys of senior bank financial officers regarding their preferences on discount window operating days and strategies for man…
The Federal Reserve Board published its annual assessment of American household economic conditions for 2025. The report provides data on household finances, employment, and econom…
The Federal Reserve Board has terminated enforcement actions with F&M Holding Company, Inc. and Thread Bancorp, Inc. The action indicates these institutions have resolved complianc…
The FDA has finalized its post-market assessment program for food chemicals and initiated a reassessment of BHT and ADA safety. This action is part of the FDA's expanded food safet…
The FDA announced it is seeking stakeholder input on drug repurposing efforts to address unmet medical needs across various diseases and conditions. The initiative aims to leverage…
The Federal Reserve Board has approved related applications submitted by Columbia Bank MHC and Columbia Financial, Inc. The approval allows these entities to proceed with their reg…
The FDA granted approval for Bizengri (zenocutuzumab-zbco), marking the seventh approval under the National Priority Voucher Pilot Program. The drug treats NRG1 fusion-positive cho…
The FDA released final guidance recommending methodologies for studying drug and biologic safety during pregnancy in the postapproval setting. The guidance aims to improve collecti…
The FDA announced the launch of Elsa 4.0, an upgraded internal AI tool now available to all agency staff including scientific reviewers and investigators. The initiative is part of…
The FDA announced a pilot program for one-day inspectional assessments to make its inspectional resources more targeted and efficient. The initiative is part of the agency's broade…
The FDA approved the marketing of four Glas ENDS products through the premarket tobacco product application pathway. This authorization expands market access for the company's elec…